Skip to main content
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.
Causes of death in hyper-IgE syndrome.
Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy.
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.
Gene therapy for immune disorders: good news tempered by bad news.
Development of population-based newborn screening for severe combined immunodeficiency.
Primary immunodeficiency diseases: an update.
Successes and risks of gene therapy in primary immunodeficiencies.
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.
Molecular interactions between glucocorticoid and catecholamine signaling pathways.